• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$11.50 $0.34 (3.05%)

REAL-TIME: Last trade at

Vascular Solutions, Inc.

NASDAQ:VASC

Vascular Solutions to Participate in the Jefferies 2012 Global Healthcare Conference

Vascular Solutions to Participate in the Jefferies 2012 Global Healthcare Conference

Vascular Solutions to Participate in the Jefferies 2012 Global Healthcare Conference

Vascular Solutions to Participate in the 2012 InvestMNt Conference Sponsored by the CFA Society of Minnesota

Benchmark Starts Vascular Solutions (VASC) at Buy; Catheter Products are Key

Vascular Solutions initiated with a Buy at Benchmark Co.

Vascular Solutions to Participate in Bank of America Merrill Lynch 2012 Health Care Conference

Dougherty & Co Upgrades Vascular Solutions (VASC) to Buy; Strong Q1 and Improved Outlook

Vascular Solutions upgraded to Buy from Neutral at Dougherty

Canaccord Genuity Maintains a 'Buy' on Vascular Solutions (VASC); Raising PT After Strong Results

Vascular Solutions raises FY12 EPS view to 53c-57c from 51c-55c, consensus 54c

Vascular Solutions reports Q1 EPS 12c, consensus 11c

Vascular Solutions, Inc. (VASC) Tops Q1 EPS by 1c; Guides for Q2 and FY

Vascular Solutions Reports First Quarter Results

Vascular Solutions, Inc. to Webcast First Quarter Conference Call on Tuesday, April 24th at 3:30pm CST

CEO pay watch: Vascular Solutions' Root: $1.1 million

Vascular Solutions announces 1M share repurchase plan

Vascular Solutions sees FY12 EPS 51c-55c vs. consensus 54c

Vascular Solutions sees Q1 EPS 10c-11c vs. consensus 12c

Vascular Solutions reports Q4 EPS 13c vs. consensus 13c

Vascular Solutions Reports Fourth Quarter Results

Vascular Solutions Launches Reprocessing Service for ClosureFAST(R) Vein Catheters

Earnings Preview: Cars, Banking and Medical

Vascular Solutions, Inc. to Webcast Fourth Quarter Conference Call on Wednesday, February 1st at 3:30 p.m. CST

Vascular Solutions, Inc. to Webcast Fourth Quarter Conference Call on Wednesday, February 1st at 3:30 p.m. CST

Feltl's 2012 Top Idea List

Is Nxstage Medical Heading for a Slowdown?

10 Game-Changing Health Care Stocks to Buy

Vascular Solutions to Present at the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Conference

Vascular Solutions to Present at the 23rd Annual Piper Jaffray Health Care Conference

Vascular Solutions to Present at the 23rd Annual Piper Jaffray Health Care Conference

Despite Weak Q3 Results Vascular Solutions Continues To Look Like A Good Long-Term Buy

A Hidden Reason Why the Future Looks Bright for Vascular Solutions

Vascular Solutions downgraded to Neutral from Buy at Dougherty

Canaccord Genuity Maintains a 'Buy' on Vascular Solutions (VASC); Mixed Q3 and Underwhelming Guidance

Vascular Solutions, Inc. (VASC) Tops Q3 EPS by 2c, Posts Q4 and FY12 Guidance, Raises FY11

Vascular Solutions sees 2012 EPS ex-items 51c-55c vs. consensus 64c

Vascular Solutions sees 2011 EPS 56c-58c vs. consensus 56c

Vascular Solutions reports Q3 EPS 22c vs. consensus 20c

Vascular Solutions sees Q4 EPS 12c-14c vs. consensus 15c

See More Articles...